Skip to main content
Midas Edge

BIO KEY INTERNATIONAL INC

For the period ended Dec 31, 2025. Filed Jun 12, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Jun 12, 2026

BKYI$2.39+0.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 16. Form 10-K Summary

None.

FINANCIAL STATEMENTS

The following financial statements of BIO-key International, Inc. are included herein at the indicated page numbers:

Report of Independent Registered Public Accounting Firm (Bush and Associates CPA., PCAOB ID:6797)41
Consolidated Balance Sheets —Years ended December 31, 2025 and 202442
Consolidated Statements of Operations and Comprehensive Loss—Years ended December 31, 2025 and 202443
Consolidated Statements of Stockholders’ Equity —Years ended December 31, 2025 and 202444
Consolidated Statements of Cash Flows—Years ended December 31, 2025 and 202445
Supplementary Disclosures of Cash Flow Information—Years ended December 31, 2025 and 202446
Notes to the Consolidated Financial Statements—December 31, 2025 and 202447
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.